Limbrel Linked to Possible Fatal Adverse Events
Efficacy Studied Following Accelerated Drug Approvals
Flimsy Evidence Behind Many FDA Approvals
DEA Proposes Cutting Production of Come Opioids
Rheumatologists Respond to Prescription Opioid Analgesic Crisis
FDA Drug Labeling, Approval Process Help Minimize Lawsuits Against Pharmaceutical Companies
As Biosimilars Hit, EU Pharma Warns against Blanket Prescribing
ACR Releases New Position Statements on Site of Service & Compounding
Insights into Drug-Related Interactions in Older Adults
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 19
- Next Page »